Glenn Greenberg's Portfolio

Brave Warrior Advisors 13F holdings

What is Glenn Greenberg's portfolio?

Brave Warrior Advisors has disclosed a total of 11 security holdings in their (2013 Q2) SEC 13F filing(s) with portfolio value of $2,159,708,000.

What stocks does Glenn Greenberg own?

In Glenn Greenberg's portfolio as of 30 Jun 2013, the top 5 holdings are (VRX) VALEANT PHARMACEUTICALS INTL (26.53%), (VPRT) VISTAPRINT NV ORD SHS (NL) (13.15%), (ESRX) EXPRESS SCRIPTS HOLDING CO (11.99%), (SCHW) SCHWAB (CHARLES) CORP (9.20%) and (ORCL) ORACLE CORP (8.70%).

To see the historical data of Brave Warrior Advisors's portfolio holdings please click on the "2013 Q2" dropdown menu and select the date.

To see Brave Warrior Advisors's original 13F reports (2013 Q2), please click on the "important" button.

Portfolio value: $2,159M+
Period: 2013 Q2
Number of stock: 11
Update: 14 Aug 2013
CMCSK
5.07%
2,759,871
$39.67
-
$109,484,000
buy or own*
+5.07%
ESRX
11.99%
3,292,604
$61.74
-
$203,285,170
buy or own*
+11.99%
FISV
4.54%
4,488,724
$21.85
422.73% $114.23
$98,090,000
buy or own*
+4.54%
8888000D
3.14%
77,016
$880.38
-
$67,803,000
buy or own*
+3.14%
HAL
8.49%
3,384,053
$41.72
23.75% $31.81
$141,182,580
buy or own*
+8.49%
1580477D
3.41%
6,319,325
$11.64
-
$73,557,000
buy or own*
+3.41%
ORCL
8.70%
6,115,172
$30.71
519.90% $190.37
$187,797,000
buy or own*
+8.70%
PRI
5.78%
2,518,661
$37.44
714.45% $304.93
$94,298,745
buy or own*
+5.78%
SCHW
9.20%
9,363,034
$21.23
287.42% $82.25
$198,777,000
buy or own*
+9.20%
VRX
26.53%
6,657,451
$86.08
-
$573,073,000
buy or own*
+26.53%
VPRT
13.15%
4,255,510
$49.37
-
$210,094,880
buy or own*
+13.15%
11 of 11

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Buy or own - this means there is no earlier reporting (for us or in general).
So we can't know if the actual purchase of the security happened at the reported period or earlier.